Form 4: Lexeo Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Richard Nolan Townsend, Chief Executive Officer and a Director of Lexeo Therapeutics, Inc., sold 3,345 shares of common stock on August 18, 2026 for $4.95 per share.
Summary
- Open-market sale: disposed of 3,345 Common Stock at $4.95 ($16,562) on August 18, 2026; holds 374,472 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $16,562 of stock on the open market.
Insider Transactions
Richard Nolan Townsend — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 3,345 | $5 | $16.6K | 374,472 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (3,345 shares) |
Keywords
insider transaction, Form 4, LXEO, Lexeo Therapeutics, Inc., bearish, Richard Nolan Townsend
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.